PharmaLectures.com

Courses › Country and business playbooks › Selling into Europe as a biologics and biosimilars maker from Türkiye

Selling into Europe as a biologics and biosimilars maker from Türkiye

Get your Turkish biosimilar to European hospitals without months lost to rework.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Türkiye, Biologics and biosimilarswho it is written for

Why this training matters

Day 120 arrives and the European Medicines Agency committee asks for comparability data that Module 2 never made easy to find. The clock stops while your scientists repeat work. Your distributor in Germany asks for a new launch date, and nobody can say when the clock restarts.

What changes after this course

Your team files Modules 1 and 2 so the reviewer finds the answer first, prices for each country, and ships with a temperature record that holds. You hold a certificate per learner and a training record for every person, ready for an inspector.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory team reads a Day 120 list of questions from the Committee for Medicinal Products for Human Use and knows which answer closes it. They build Common Technical Document Modules 1 and 2 against Directive 2001/83 and the guideline on similar biological medicinal products, so the comparability data sits where the reviewer looks for it. The clock stops less often.

Before the inspector arrives, the quality assurance lead checks the site against EudraLex Volume 4, including Annex 2 for biological medicines. When someone asks who certifies a batch, the answer is already on file: Annex 16, the Qualified Person at the importing site in the Union, and the batch record that person signs from. Nobody scrambles on inspection day.

Market access managers arrive at a national assessment meeting with the evidence that body asks for, and with prices that other countries will read across through external reference pricing. Supply chain staff pack to the Falsified Medicines Directive and Delegated Regulation 2016/161, and keep cold chain records to Chapter 9 of the Good Distribution Practice guidelines. A gap in the temperature record gets an answer before the buyer asks.

Pharmacovigilance officers check the reference dates list, name the qualified person for the European Economic Area, and send each periodic safety update report before anyone chases it. Legal staff read supplementary protection certificates under Regulation 469/2009 before a launch date is set. Regulatory staff pick the right Type IA, Type IB or Type II variation when the process changes, and the forwarder gets the A.TR movement certificate right the first time.

Who needs this training

  • Regulatory Affairs Manager

    The Day 120 list of questions arrives and half the queries point to comparability data placed where the reviewer did not expect it in Module 2.

  • Market Access Manager

    A payer in Germany or France asks what evidence backs your biosimilar and your price, and you answer from one prepared pack instead of writing it that night.

  • Quality Assurance Lead

    A European inspector asks who certifies the batch under Annex 16 and which records show your cold storage held its labelled range, and the answers are in one file.

  • Pharmacovigilance Officer

    A periodic safety update report falls due and you need its date from the reference dates list and the name of the person who signs for the European Economic Area.

  • Export and Supply Chain Manager

    A consignment of biologics waits at the border because the A.TR movement certificate or the temperature record does not match the shipping paperwork.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: Biologics and biosimilars

Countries: Türkiye

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Draft Common Technical Document Module 2 overviews that place the comparability data where a reviewer expects to find it.
  2. Name the three European roles your filing needs: marketing authorization holder, Qualified Person and qualified person responsible for pharmacovigilance.
  3. Check a batch file against Annex 16 and mark every gap before the importer's Qualified Person finds it.
  4. Build a price corridor for one country that shows how external reference pricing carries into the next launch.
  5. Write a temperature record for a cold chain shipment that matches Chapter 9 of the Good Distribution Practice guidelines.
  6. Find the next due date of a periodic safety update report on the European Union reference dates list.
  7. Read a supplementary protection certificate and state the date it ends under Regulation 469/2009.

What the company gets

  • Your regulatory team sends dossiers that answer the reviewer's first questions, so months of clock-stop stop being part of the launch plan.
  • Your quality unit hands an inspector a batch file that already answers the Annex 16 questions, and a site record that holds up on the walk through.
  • Your market access staff meet payers in Germany and France with a prepared evidence pack and a price that survives external reference pricing.
  • Your legal team flags a supplementary protection certificate before a launch date is promised to a distributor or a hospital.
  • Every learner finishes with a certificate and a training record, so you can show an inspector who was trained on what.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Run the European Medicines Agency centralized procedure without losing months

    • Why your biosimilar must go through the centralized procedure, and how that sets your filing plan.
    • How to answer the Day 120 list of questions from the scientific committee in one pass.
    • Why the marketing authorization holder must sit inside the European Economic Area, and who that can be.
  2. 2Write Common Technical Document Modules 1 and 2 with no data gaps

    • The Module 2 summaries a reviewer reads first, and how to write them so no question starts there.
    • How to lay out comparability data against the reference product so biosimilarity reads at a glance.
    • What to do when Module 1 forms, product information and Module 3 quality data disagree before submission.
  3. 3Pass European Good Manufacturing Practice inspections at your Turkish site

    • What an inspector from a European authority asks to see on the walk through your biologics site.
    • How Annex 2 on biological medicinal products shapes your cell bank, process control and batch records.
    • Why Annex 16 and the Qualified Person at the European importer decide whether your batch ships.
  4. 4Clear national Health Technology Assessment evaluations with the right data

    • Which evidence a national assessment body wants for a biosimilar, and which it leaves to the regulator.
    • When to lean on the European Medicines Agency finding of biosimilarity, and when payers want more.
    • How to prepare one evidence pack per country so the Germany reply is not the France reply rewritten.
  5. 5Set biosimilar prices that hold up against European reference models

    • How external reference pricing carries one country's low price into your next launch.
    • The tender rules that decide who wins volume, and how to price to win them without gutting your margin.
    • How to build a launch price corridor from the reference product price before you meet any payer.
  6. 6Ship cold chain biologics under Good Distribution Practice rules

    • How to document the labelled storage range on every leg, so a temperature excursion has an answer.
    • What Chapter 9 of the Good Distribution Practice guidelines, Transportation, requires of your carrier.
    • Why the Falsified Medicines Directive unique identifier and tamper seal change your pack before you ship.
  7. 7Submit periodic safety update reports that European regulators accept

    • How to read the European Union reference dates list to learn when your first safety report falls due.
    • What the qualified person responsible for pharmacovigilance must hold and sign in the European Economic Area.
    • What to do when a serious adverse reaction arrives and the reporting clock has already started.
  8. 8Clear European Union-Türkiye Customs Union non-tariff barriers at the border

    • Why free movement under the Customs Union does not remove batch testing and importer checks on arrival.
    • How to fill in the A.TR movement certificate so the consignment is not held at the border.
    • The export papers from Türkiye your forwarder needs, listed so the shipment file is ready the day before.
  9. 9Pitch national health authorities and hospital formulary committees

    • How to open a health authority meeting with the one point the official needs to take away.
    • What a formulary committee needs from you before it will table a switch from the reference product.
    • Why the same pitch lands in one country and fails in the next, and how to adjust before the meeting.
  10. 10Spot supplementary protection certificates before you set a launch date

    • How to read a supplementary protection certificate under Regulation 469/2009 and find its end date.
    • Why the patent expiry in a database can sit years before the date you can legally launch.
    • When to ask your patent counsel for a freedom-to-operate opinion, and when the file already answers it.
  11. 11Draft promotional materials that meet European ethical guidelines

    • Why European Union advertising rules bar prescription medicines from being promoted to the public.
    • How to keep every claim in a brochure inside the Summary of Product Characteristics.
    • The wording you can use when you talk switching with doctors, and the wording that breaks the national code.
  12. 12File variation applications that keep your marketing authorization active

    • How to tell a Type IA, Type IB and Type II variation apart before you pick the form.
    • What to do when a manufacturing site or process change touches your approved biosimilar.
    • How the five-year renewal works, and what to have in the file before the date arrives.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Türkiye, Biologics and biosimilars. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team